MedTrace Logo

Nicotine Patch, Blood Flow and Oxidative Stress Study

NCT00954096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2009-10-27

No results posted yet for this study

Summary

This study will address the hypothesis that nicotine, like cigarette smoking acting as a pro-oxidant may have adverse effects on arterial function.

Conditions

  • Healthy

Interventions

DRUG

transdermal nicotine patch (7mg)

A 7mg transdermal nicotine patch will be applied to the subject's arm for an 8 hour period.

Sponsors & Collaborators

Principal Investigators

  • Garret A FitzGerald, MD · University of Pennsylvania Institute for Translational Medicine and Therapeutics

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2006-11-30
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00954096 on ClinicalTrials.gov